{
    "clinical_study": {
        "@rank": "78926", 
        "arm_group": [
            {
                "arm_group_label": "Low Value Alternative Reinforcer", 
                "arm_group_type": "Experimental", 
                "description": "A low value reinforcer will be made available as an alternative to cocaine and placebo."
            }, 
            {
                "arm_group_label": "Medium Value Reinforcer", 
                "arm_group_type": "Experimental", 
                "description": "A medium value reinforcer will be made available as an alternative to cocaine and placebo."
            }, 
            {
                "arm_group_label": "High Value Reinforcer", 
                "arm_group_type": "Experimental", 
                "description": "A high value reinforcer will be made available as an alternative to cocaine and placebo."
            }
        ], 
        "brief_summary": {
            "textblock": "Cocaine-use disorders continue to be a significant public health concern, yet no effective\n      medications have been identified. The goal of this study is to establish a research platform\n      for the development of medications for treatment of cocaine abuse and dependence. This study\n      will incorporate self-administration procedures and a non-drug alternative reinforcer, which\n      is hypothesized to reduce the reinforcing effects of cocaine."
        }, 
        "brief_title": "Impact of a Non-Drug Choice on Cocaine Reinforcement", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Cocaine Dependence", 
        "condition_browse": {
            "mesh_term": "Cocaine-Related Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Cocaine dependence, otherwise healthy\n\n        Exclusion Criteria:\n\n          -  Laboratory results outside of clinically acceptable ranges, history of or current\n             serious physical or psychiatric disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "8", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01906346", 
            "org_study_id": "R01-DA033364-01"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Low Value Alternative Reinforcer", 
                    "Medium Value Reinforcer", 
                    "High Value Reinforcer"
                ], 
                "description": "Three active doses of cocaine will be made available for self-administration during experimental sessions.", 
                "intervention_name": "Cocaine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Low Value Alternative Reinforcer", 
                    "Medium Value Reinforcer", 
                    "High Value Reinforcer"
                ], 
                "description": "Placebo cocaine will be made available for self-administration during experimental sessions.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Cocaine"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "July 19, 2013", 
        "location": {
            "contact": {
                "last_name": "Frances Wagner, RN", 
                "phone": "859-257-5388"
            }, 
            "facility": {
                "address": {
                    "city": "Lexington", 
                    "country": "United States", 
                    "state": "Kentucky", 
                    "zip": "40536-0086"
                }, 
                "name": "Laboratory of Human Behavioral Pharmacology"
            }, 
            "investigator": {
                "last_name": "Joshua Lile, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "Impact of a Non-Drug Choice on Cocaine Reinforcement", 
        "overall_contact": {
            "last_name": "William W Stoops, Ph.D.", 
            "phone": "859-257-5388"
        }, 
        "overall_official": {
            "affiliation": "University of Kentucky", 
            "last_name": "Joshua A Lile, Ph.D", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The reinforcing effects of cocaine will be assessed when an alternative reinforcer of varying values is available as an alternative using a modified progressive-ratio procedure.", 
            "measure": "Number of injections of self-administered cocaine", 
            "safety_issue": "No", 
            "time_frame": "per 6-hr daily session, 13 total sessions"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01906346"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Kentucky", 
            "investigator_full_name": "Joshua A. Lile, Ph.D.", 
            "investigator_title": "Joshua A. Lile, Ph.D., Associate Professor of Behavioral Science", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Subjects will complete a subjective effects questionnaire that will include items relating to drug effects and general mood and rated on a 100-unit Visual Analog Scale.", 
                "measure": "Visual Analog Scale Subjective Effects Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "per 6-hr daily session, 13 total sessions"
            }, 
            {
                "description": "Physiological measures include heart rate and blood pressure.", 
                "measure": "Physiological Effects", 
                "safety_issue": "Yes", 
                "time_frame": "per 6-hr daily session, 13 total sessions"
            }, 
            {
                "description": "Side Effects questions will query subjects about common effects of centrally active medications.", 
                "measure": "Side Effects Questionnaire", 
                "safety_issue": "Yes", 
                "time_frame": "per 6-hr daily session, 13 total sessions"
            }
        ], 
        "source": "University of Kentucky", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Kentucky", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}